CCL3−/− mice show reduced lesion sizes and plaque formation in atherosclerosis [74] and blockade of CCR5, using neutralizing antibodies, promotes locomotor recovery after SCI [75]. This evidence concerns the gene CCR5 and atherosclerosis.